Auswahl der wissenschaftlichen Literatur zum Thema „Liver radioembolization“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Liver radioembolization" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Liver radioembolization":
Carrion-Martin, L., J. Orcajo Rincón, A. Rotger, M. Gonzalez-Leyte, L. Márquez Pérez, M. Echenagusia und A. Matilla. „Radioembolization in liver tumors“. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 38, Nr. 6 (November 2019): 370–81. http://dx.doi.org/10.1016/j.remnie.2019.06.005.
Braat, Manon N. G. J. A., Karel J. van Erpecum, Bernard A. Zonnenberg, Maurice A. J. van den Bosch und Marnix G. E. H. Lam. „Radioembolization-induced liver disease“. European Journal of Gastroenterology & Hepatology 29, Nr. 2 (Februar 2017): 144–52. http://dx.doi.org/10.1097/meg.0000000000000772.
Braat, A. J. A. T., H. Ahmadzadehfar, S. C. Kappadath, C. L. Stothers, A. Frilling, C. M. Deroose, P. Flamen et al. „Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases After Initial Peptide Receptor Radionuclide Therapy“. CardioVascular and Interventional Radiology 43, Nr. 2 (23.10.2019): 246–53. http://dx.doi.org/10.1007/s00270-019-02350-2.
Birgin, Emrullah, Erik Rasbach, Steffen Seyfried, Nils Rathmann, Steffen J. Diehl, Stefan O. Schoenberg, Christoph Reissfelder und Nuh N. Rahbari. „Contralateral Liver Hypertrophy and Oncological Outcome Following Radioembolization with 90Y-Microspheres: A Systematic Review“. Cancers 12, Nr. 2 (27.01.2020): 294. http://dx.doi.org/10.3390/cancers12020294.
Facciorusso, Antonio, Irene Bargellini, Marina Cela, Ivan Cincione und Rodolfo Sacco. „Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis“. Cancers 12, Nr. 4 (07.04.2020): 897. http://dx.doi.org/10.3390/cancers12040897.
De Souza, Andre, Kevin Pelham Daly, James Yoo und Muhammad Wasif Saif. „Safety and Efficacy of Combined Yttrium 90 Resin Radioembolization with Aflibercept and FOLFIRI in a Patient with Metastatic Colorectal Cancer“. Case Reports in Oncological Medicine 2015 (2015): 1–6. http://dx.doi.org/10.1155/2015/461823.
Elsayed, Mohammad, Robert M. Ermentrout, Ila Sethi, Zachary L. Bercu, James R. Galt, Morgan Whitmore, David C. Brandon, David M. Schuster und Nima Kokabi. „Incidence of Radioembolization-Induced Liver Disease and Liver Toxicity Following Repeat 90Y-Radioembolization“. Clinical Nuclear Medicine 45, Nr. 2 (Februar 2020): 100–104. http://dx.doi.org/10.1097/rlu.0000000000002828.
Lebedev, Dmitry Petrovich, Dmitry Nikolaevich Panchenkov, Yuri Viktorovich Ivanov, Dmitry Anatolievich Astakhov und Elena Alexandrovna Zvezdkina. „RADIOEMBOLIZATION AS A METHOD FOR THE TREATMENT OF UNRESECTABLE PRIMARY AND METASTATIC LIVER CANCER (LITERATURE REVIEW)“. Journal of Experimental and Clinical Surgery 13, Nr. 1 (25.02.2020): 61–69. http://dx.doi.org/10.18499/2070-478x-2020-13-1-61-69.
Laidlaw, Grace L., und Guy E. Johnson. „Recognizing and Managing Adverse Events in Y-90 Radioembolization“. Seminars in Interventional Radiology 38, Nr. 04 (Oktober 2021): 453–59. http://dx.doi.org/10.1055/s-0041-1735617.
Kiszka, Joanna, und Bożenna Karczmarek-Borowska. „Radioembolization treatment for liver metastases“. Współczesna Onkologia 21, Nr. 4 (2017): 274–78. http://dx.doi.org/10.5114/wo.2017.72153.
Dissertationen zum Thema "Liver radioembolization":
Levillain, Hugo. „Prediction and improvement of radioembolization outcome using personalised treatment and dosimetry“. Doctoral thesis, Universite Libre de Bruxelles, 2021. https://dipot.ulb.ac.be/dspace/bitstream/2013/320561/3/PhDTM.docx.
Doctorat en Sciences biomédicales et pharmaceutiques (Médecine)
info:eu-repo/semantics/nonPublished
Hammami, Houda. „Guidance of radioembolization procedures in the context of interventional oncology“. Thesis, Rennes 1, 2021. http://www.theses.fr/2021REN1S121.
Radioembolization is a minimally-invasive intervention performed to treat liver cancer by administering radioactive microspheres. In order to optimize radioembolization outcomes, the procedure is carried out in two sessions: pretreatment assessment intervention, mainly performed to locate the injection site, assess microspheres distribution and perform dosimetry evaluation, and treatment intervention performed to inject the estimated proper dose of radioactive microspheres in the located injection site. Due to the hepatic vasculature complexity, interventional radiologists carefully manipulate the catheter, during the two interventions, under X-Ray image guidance and resort to contrast media injection in order to highlight vessels. In this thesis, we propose a novel guidance strategy that promises a simplification and accuracy of the catheter navigation during the pretreatment assessment, as well as during the treatment interventions. The proposed navigation system processes pre- and intraoperative images to achieve intraoperative image fusion through a rigid registration technique. This approach is designed to 1) assist the celiac trunk access, 2) assist the injection site access and 3) automatically reproduce the injection site during the proper intervention. Knowing that the liver undergoes a motion induced by the breathing, we also propose an approach that allows obtaining a dynamic overlay of the projected 3D vessels onto fluoroscopy
Vouche, Michael. „Radiation Segmentectomy, Radiation Lobectomy and Response Assessment after 90Yttrium Radioembolization for Hepatocellular carcinoma: Imaging and Clinical Implications“. Doctoral thesis, Universite Libre de Bruxelles, 2017. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/241979.
Doctorat en Sciences médicales (Médecine)
info:eu-repo/semantics/nonPublished
Ferreira, Bárbara Mendes. „Radioembolização de metástases hepáticas do carcinoma colorretal“. Master's thesis, 2021. http://hdl.handle.net/10400.6/11316.
Introduction: The role of radioembolization (RE) in liver dominant metastatic colorectal cancer (lmCRC) is unclear. This research aims to assess the prognostic factors and outcomes of RE in these patients. Methodology: A retrospective analysis of all patients with lmCRC who underwent RE in Instituto Português de Oncologia do Porto, from January 2011 to March 2020, was performed. The one-year survival was evaluated with the Kaplan-Meier method and potential prognostic factors were analyzed using the log-rank test, Mann-Whitney test, chisquare test, Fisher’s test, and t-test for independent samples. Results: Thirty patients were analyzed. The median age was 61,5 years and most patients were male (63,3%). There was a low complication rate. Successful RE was observed in 50% of the cases. Lower cancer stage, CEA levels at diagnosis lower than 20ng/mL, more than one year between diagnosis of CRC and the emergence of liver metastases, absence of vascular or lymphatic invasion at the moment of diagnosis were significantly associated with a successful RE (P values of <0,001, 0,035, 0,036, 0,028 and 0,020, respectively). The one-year survival of patients with and without successful RE was 9,4 months (CI 95%, 1,8- 17,1) and 8,9 months (CI 95%, 7,5-10,2), respectively. Conclusion: Several factors increase the likelihood of achieving a successful RE. The RE was considered a well-tolerated procedure, with easily managed complications and a low complication rate. However, more studies with larger cohorts are needed to validate this procedure.
Μουντρής, Κωνσταντίνος. „Ακτινοεμβολισμός ήπατος με μικροσφαιρίδια Υ-90 : Διερεύνηση της μεθόδου και βελτιστοποίηση με χρήση εξομοιώσεων Monte Carlo“. Thesis, 2014. http://hdl.handle.net/10889/8152.
Investigation of the method of radioembolization with Y90 microspheres for the treatment of liver malignancies. Improvement of the image-based dosimetry proposing the use of PET tracers.
Bücher zum Thema "Liver radioembolization":
Bilbao, José I., und Maximilian F. Reiser, Hrsg. Liver Radioembolization with 90Y Microspheres. Berlin, Heidelberg: Springer Berlin Heidelberg, 2008. http://dx.doi.org/10.1007/978-3-540-35423-9.
Bilbao, José Ignacio, und Maximilian F. Reiser, Hrsg. Liver Radioembolization with 90Y Microspheres. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-36473-0.
Bilbao, José I. Liver Radioembolization with 90Y Microspheres. Berlin, Heidelberg: Springer-Verlag Berlin Heidelberg, 2008.
Reiser, Maximilian F., und José Ignacio Bilbao. Liver Radioembolization with 90Y Microspheres. Springer, 2014.
Reiser, Maximilian F., und José Ignacio Bilbao. Liver Radioembolization with 90Y Microspheres. Springer, 2016.
Bradley, Yong, Alexander S. Pasciak und J. Mark McKinney. Handbook of Radioembolization: Physics, Biology, Nuclear Medicine, and Imaging. Taylor & Francis Group, 2016.
Buchteile zum Thema "Liver radioembolization":
Sangro, Bruno, Mercedes Iñarrairaegui und Andrew S. Kennedy. „Radioembolization-Induced Liver Disease“. In Liver Radioembolization with 90Y Microspheres, 177–85. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/174_2013_817.
Martínez-Ortega, Patricia, Fernando Pardo und Bruno Sangro. „Surgical Treatment and Radioembolization“. In Liver Radioembolization with 90Y Microspheres, 167–70. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/174_2013_947.
Salem, Riad, Saad Ibrahim, Bassel Atassi und Robert J. Lewandowski. „Future Directions in Radioembolization“. In Liver Radioembolization with 90Y Microspheres, 147–56. Berlin, Heidelberg: Springer Berlin Heidelberg, 2008. http://dx.doi.org/10.1007/978-3-540-35423-9_15.
Kutlu, Ramazan, Sinan Karatoprak und Müge Otlu Karadağ. „Transarterial Radioembolization in Hepatocellular Carcinoma“. In Liver Cancer in the Middle East, 137–69. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-78737-0_9.
Shah, Rajesh P., und Daniel Y. Sze. „Radioembolization: Identifying and Managing Anatomic Variants“. In Liver Radioembolization with 90Y Microspheres, 41–52. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/174_2013_886.
Salem, Riad, Robert J. Lewandowski, Robert K. Ryu, Kent Sato und Antonio Martinez de la Cuesta. „Radioembolization : Identifying and Managing Anatomic Variants“. In Liver Radioembolization with 90Y Microspheres, 43–50. Berlin, Heidelberg: Springer Berlin Heidelberg, 2008. http://dx.doi.org/10.1007/978-3-540-35423-9_5.
Trumm, C., R. T. Hoffmann, T. F. Jakobs und M. F. Reiser. „Regulations and Requirements of Hospitals Performing Radioembolization“. In Liver Radioembolization with 90Y Microspheres, 11–14. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/174_2013_809.
Zech, Christoph J., und M. F. Reiser. „Radiological Evaluation of Patients with Liver Tumors“. In Liver Radioembolization with 90Y Microspheres, 15–26. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/174_2013_810.
Saiz-Mendiguren, Ramón, Javier Arias, Isabel Vivas und José Ignacio Bilbao. „Vascular Anatomy and Its Implication in Radioembolization“. In Liver Radioembolization with 90Y Microspheres, 27–40. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/174_2013_811.
Coldwell, Douglas M., Martin Vyleta und Mahmood Samman. „Treatment of Neuroendocrine Tumors with Selective Internal Radiation Therapy“. In Liver Radioembolization with 90Y Microspheres, 151–55. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/174_2013_812.
Konferenzberichte zum Thema "Liver radioembolization":
Taebi, Amirtahà, Catherine T. Vu und Emilie Roncali. „Prediction of Blood Flow Distribution in Liver Radioembolization Using Convolutional Neural Networks“. In ASME 2020 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2020. http://dx.doi.org/10.1115/imece2020-24475.
Guerra, JM, M. Mustafa, M. Krönke, N. Navab, SG Nekolla, WA Weber und T. Wendler. „Novel Low-Dose CT based Automatic Segmentation and Registration Framework for Liver Radioembolization Planning“. In NuklearMedizin 2021 – digital. Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1726852.
Taebi, Amirtaha, Catherine T. Vu und Emilie Roncali. „Estimation of Yttrium-90 Distribution in Liver Radioembolization using Computational Fluid Dynamics and Deep Neural Networks“. In 2020 42nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) in conjunction with the 43rd Annual Conference of the Canadian Medical and Biological Engineering Society. IEEE, 2020. http://dx.doi.org/10.1109/embc44109.2020.9176328.
Ghandour, A., X. Li, L. Nasehi, S. Shrikanthan, F. DiFilippo, R. Gurajala und Gordon Mclennan. „Surefire Infusion System versus Non-Surefire Y-90 Radioembolization of Non Resectable Liver Tumors: A Retrospective Review“. In Abstracts of 3rd Annual Meeting of the American Society of Digestive Disease Interventions. Thieme Medical Publishers, 2017. http://dx.doi.org/10.1055/s-0037-1603697.
Wang, Chongkai, John Park, Ching Ouyang, Raju Pillai, Jeffrey Longmate, Holly Yin, Christian Avalos et al. „Abstract 528: Radioembolization followed by durvalumab and tremelimumab does not induce immune responses against liver-metastasized MSS colorectal cancer“. In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-528.
Wang, Chongkai, John Park, Ching Ouyang, Raju Pillai, Jeffrey Longmate, Holly Yin, Christian Avalos et al. „Abstract 528: Radioembolization followed by durvalumab and tremelimumab does not induce immune responses against liver-metastasized MSS colorectal cancer“. In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-528.